[13] DSS Model Results : Weight loss significantly reduced at day 8 Myeloperoxidase activity (neutrophil marker) dropped 50% Prevented colon weight increase and length decrease IL-6 and IL-12 mRNA expression significantly reduced Histology showed less inflammation, reduced cell damage, fewer inflammatory cells in tissue layers TNBS Model Results (more acute inflammation): Weight loss reduced within 1-2 days post-TNBS Colonic MPO activity decreased 30% Prevented TNBS-induced colon shortening Broad cytokine suppression: IL-1, IL-6, TNF-, IFN- mRNA all reduced KPV didnt affect inflammatory markers in healthy mice
doi: 10.1172/jci.insight.158193 525 SpolskiRLeonardWJ
Ultimately, the choice depends on treatment goals, budget, and individual response to therapy
The modifications made Dihexa much more bioavailable and durable, allowing it to cross the blood-brain barrier
E como os produtos qumicos so considerados de "grau de pesquisa" e destinados apenas ao trabalho de laboratrio, os reguladores no exigem as mesmas medidas de qualidade usadas para medicamentos aprovados